Preclinical evidence

The Triflo valve is the result of years of research in collaboration with world leaders in aeronautics, medicine, and science. Exhaustive in-vitro and in-vivo testing performed on the valve suggest its safety and effectiveness.

 

57

In-vitro testing

The design of the valve has been validated by means of state-of-the-art experimental and numerical testing:

  • Hydrodynamic performance
  • Structural performance
  • Durability and wear tests
     

Novostia

 

Extensive comparative in-vitro testing has been performed by independent institutes, including:

  • École Polytechnique Fédérale de Lausanne (EPFL)
  • Swiss Federal Institute of Technology, Zürich (ETH)
  • Bern University, Artorg Center Biomedical Engineering Research (Bern, Switzerland)
  • Vivitro Systems, Inc. (Victoria, Canada)
  • Helmholtz-Institute (Aachem, Germany)
  • California Institute of Technology, CALTECH (Pasadena, California, U.S.A.)
  • Simulog (Toulouse, France)

 

58

In-vivo testing

Novostia in vivo testing

 

More than 100 successful long-term (up to 1.5 years) anticoagulant-free animal implants have been performed with no obstructive thrombosis